Education
About Us
Working with TipRanks
Follow Us
DRI Healthcare (TSE:DHT.UN)
TSX:DHT.UN
Earnings Data
Report Date
Mar 09, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.76Last Year’s EPS
1.1Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call showcased strong financial performance, successful internalization, and strategic acquisitions, with significant growth in adjusted EBITDA and cash receipts. However, challenges with Vonjo's underperformance and Omidria's decline were noted. Overall, the highlights outweigh the lowlights.Company Guidance
Strong Financial Performance
DRI Healthcare reported total cash receipts of $43.6 million, a 12% increase over the same quarter last year. Total income was $48.7 million, a 17% increase from the previous year. Adjusted EBITDA grew by 17% year-over-year, reaching $36.7 million with an adjusted EBITDA margin of 84%.
Successful Internalization
The third quarter marked DRI's first full quarter operating as an internalized company with adjusted EBITDA margins of 84%. The company plans to optimize its internal platform, expecting costs to decrease further in the near term.
Ekterly Approval and Milestone Payment
Ekterly received approval on July 7, 2025. Calvista exercised its option for a one-time $22 million payment, increasing DRI's royalty rate on the first year of sales.
Strategic Acquisition of Veligrotug and VRDN-003 Royalties
DRI acquired synthetic royalty streams on Veligrotug and VRDN-003 for an upfront fee of $55 million, with total investment expected up to $300 million. Veligrotug has been granted a breakthrough therapy designation from the FDA.
TSE:DHT.UN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:DHT.UN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | C$15.45 | C$15.25 | -1.29% |
Aug 13, 2025 | C$14.81 | C$14.12 | -4.66% |
May 12, 2025 | C$12.16 | C$12.20 | +0.33% |
Mar 03, 2025 | C$11.14 | C$11.74 | +5.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does DRI Healthcare (TSE:DHT.UN) report earnings?
DRI Healthcare (TSE:DHT.UN) is schdueled to report earning on Mar 09, 2026, Before Open (Confirmed).
What is DRI Healthcare (TSE:DHT.UN) earnings time?
DRI Healthcare (TSE:DHT.UN) earnings time is at Mar 09, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:DHT.UN EPS forecast?
TSE:DHT.UN EPS forecast for the fiscal quarter 2025 (Q4) is 0.76.